Selected research
Industry Research
Arthritis Drug Industry Research Report 2026
Market perspective
The global Arthritis Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Arthritis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Arthritis Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Arthritis Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Arthritis Drug include Celltrion, F. Hoffmann-La Roche, GSK, Pfizer, Eli Lilly, Novartis and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Arthritis Drug market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Arthritis Drug Market by Company
Celltrion
F. Hoffmann-La Roche
GSK
Pfizer
Eli Lilly
Novartis
Johnson & Johnson
Arthritis Drug Segment by Type
Analgesics
Biological DMARDs
Corticosteroids
Synthetic DMARDs
NSAIDs
Arthritis Drug Segment by Application
Hospital Pharmacies
Drug Stores
Retail Pharmacies
E-Commerce
Arthritis Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Arthritis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Arthritis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Arthritis Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Arthritis Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Arthritis Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Arthritis Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Analgesics
- Biological DMARDs
- Corticosteroids
- Synthetic DMARDs
- NSAIDs
Applications
- Hospital Pharmacies
- Drug Stores
- Retail Pharmacies
- E-Commerce
Companies covered
- Celltrion
- F. Hoffmann-La Roche
- GSK
- Pfizer
- Eli Lilly
- Novartis
- Johnson & Johnson
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Arthritis Drug Market Size (2021-2032)
- 2.2.2 Global Arthritis Drug Sales (2021-2032)
- 2.2.3 Global Arthritis Drug Market Average Price (2021-2032)
- 2.3 Arthritis Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Analgesics
- 2.3.3 Biological DMARDs
- 2.3.4 Corticosteroids
- 2.3.5 Synthetic DMARDs
- 2.3.6 NSAIDs
- 2.4 Arthritis Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacies
- 2.4.3 Drug Stores
- 2.4.4 Retail Pharmacies
- 2.4.5 E-Commerce
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Arthritis Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Arthritis Drug Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Arthritis Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Arthritis Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Arthritis Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Arthritis Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Arthritis Drug, Product Type & Application
- 3.8 Global Manufacturers of Arthritis Drug, Established Date
- 3.9 Global Arthritis Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Celltrion
- 4.1.1 Celltrion Company Information
- 4.1.2 Celltrion Business Overview
- 4.1.3 Celltrion Arthritis Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Celltrion Arthritis Drug Product Portfolio
- 4.1.5 Celltrion Recent Developments
- 4.2 F. Hoffmann-La Roche
- 4.2.1 F. Hoffmann-La Roche Company Information
- 4.2.2 F. Hoffmann-La Roche Business Overview
- 4.2.3 F. Hoffmann-La Roche Arthritis Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 F. Hoffmann-La Roche Arthritis Drug Product Portfolio
- 4.2.5 F. Hoffmann-La Roche Recent Developments
- 4.3 GSK
- 4.3.1 GSK Company Information
- 4.3.2 GSK Business Overview
- 4.3.3 GSK Arthritis Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 GSK Arthritis Drug Product Portfolio
- 4.3.5 GSK Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Arthritis Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Arthritis Drug Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 Eli Lilly
- 4.5.1 Eli Lilly Company Information
- 4.5.2 Eli Lilly Business Overview
- 4.5.3 Eli Lilly Arthritis Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Eli Lilly Arthritis Drug Product Portfolio
- 4.5.5 Eli Lilly Recent Developments
- 4.6 Novartis
- 4.6.1 Novartis Company Information
- 4.6.2 Novartis Business Overview
- 4.6.3 Novartis Arthritis Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Novartis Arthritis Drug Product Portfolio
- 4.6.5 Novartis Recent Developments
- 4.7 Johnson & Johnson
- 4.7.1 Johnson & Johnson Company Information
- 4.7.2 Johnson & Johnson Business Overview
- 4.7.3 Johnson & Johnson Arthritis Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Johnson & Johnson Arthritis Drug Product Portfolio
- 4.7.5 Johnson & Johnson Recent Developments
5 Global Arthritis Drug Market Scenario by Region
- 5.1 Global Arthritis Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Arthritis Drug Sales by Region: 2021-2032
- 5.2.1 Global Arthritis Drug Sales by Region: 2021-2026
- 5.2.2 Global Arthritis Drug Sales by Region: 2027-2032
- 5.3 Global Arthritis Drug Revenue by Region: 2021-2032
- 5.3.1 Global Arthritis Drug Revenue by Region: 2021-2026
- 5.3.2 Global Arthritis Drug Revenue by Region: 2027-2032
- 5.4 North America Arthritis Drug Market Facts & Figures by Country
- 5.4.1 North America Arthritis Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Arthritis Drug Sales by Country (2021-2032)
- 5.4.3 North America Arthritis Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Arthritis Drug Market Facts & Figures by Country
- 5.5.1 Europe Arthritis Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Arthritis Drug Sales by Country (2021-2032)
- 5.5.3 Europe Arthritis Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Arthritis Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Arthritis Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Arthritis Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Arthritis Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Arthritis Drug Market Facts & Figures by Country
- 5.7.1 South America Arthritis Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Arthritis Drug Sales by Country (2021-2032)
- 5.7.3 South America Arthritis Drug Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Arthritis Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Arthritis Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Arthritis Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Arthritis Drug Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Arthritis Drug Sales by Type (2021-2032)
- 6.1.1 Global Arthritis Drug Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Arthritis Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Arthritis Drug Revenue by Type (2021-2032)
- 6.2.1 Global Arthritis Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Arthritis Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Arthritis Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Arthritis Drug Sales by Application (2021-2032)
- 7.1.1 Global Arthritis Drug Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Arthritis Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Arthritis Drug Revenue by Application (2021-2032)
- 7.2.1 Global Arthritis Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Arthritis Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Arthritis Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Arthritis Drug Value Chain Analysis
- 8.1.1 Arthritis Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Arthritis Drug Production Mode & Process
- 8.2 Arthritis Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Arthritis Drug Distributors
- 8.2.3 Arthritis Drug Customers
9 Global Arthritis Drug Analyzing Market Dynamics
- 9.1 Arthritis Drug Industry Trends
- 9.2 Arthritis Drug Industry Drivers
- 9.3 Arthritis Drug Industry Opportunities and Challenges
- 9.4 Arthritis Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst